Our project portfolio in pharma and biotech strategy is expansive. Our capabilities span all stages of the product lifecycle — from early-stage opportunity assessments to inform where a product’s greatest value may lie, to comprehensive launch planning and support.
We additionally support clients in setting strategy at the franchise and corporate level — including therapeutic area strategy, licensing and acquisitions, and corporate growth strategy. We have worked in every therapeutic area, and in both developed and emerging markets.
We work with organizations big and small, from top ten pharma companies to early startups. While the solutions should be right sized for the organization, our commitment to an exceptional project experience applies to all.
We are solving the problems at new frontiers for pharma. Below, explore a few examples that spotlight our recent work.
MOA Mapping and Prioritization
Pipeline Optimization
Indication Prioritization
Product Profile Development
Opportunity Assessment
Patient Journey Assessment
Demand Assessment
Patient & Prescriber Segmentation
Revenue Forecasting
Go-to-market Strategy
Global Launch Sequencing
Lifecycle Management
Therapeutic Area Assessment
Portfolio Strategy
Competitive Intelligence
Corporate Growth Strategy
Asset Screening and Diligence
Buy- and Sell-side Due Diligence
